Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
It is important to identify patients with Maturity-onset diabetes of the young (MODY) as a molecular diagnosis determines both treatment and prognosis. Genetic testing is currently expensive and many patients are therefore not assessed and are misclassified as having either type 1 or type 2 diabetes...
Κύριοι συγγραφείς: | Gloyn, A, Faber, J, Malmodin, D, Thanabalasingham, G, Lam, F, Ueland, P, McCarthy, M, Owen, K, Baunsgaard, D |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Public Library of Science
2012
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
ανά: Anna L Gloyn, κ.ά.
Έκδοση: (2012-01-01) -
Diagnosis and management of maturity onset diabetes of the young (MODY).
ανά: Thanabalasingham, G, κ.ά.
Έκδοση: (2011) -
Diagnosis and management of maturity onset diabetes of the young (MODY).
ανά: Thanabalasingham, G, κ.ά.
Έκδοση: (2011) -
Diagnosis and management of maturity onset diabetes of the young (MODY)
ανά: Thanabalasingham, G, κ.ά.
Έκδοση: (2011) -
Mature onset diabetes of the young (MODY).
ανά: E Lacerda Nobre, κ.ά.
Έκδοση: (2002-12-01)